NL-OMON26930
Recruiting
Not Applicable
Follow-up after surgery for colorectal liver metastasis: the prospective, multicentre FUTURE-mets study
Prof. Dr. C. Verhoef, Erasmus MC Cancer Institute0 sites138 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Prof. Dr. C. Verhoef, Erasmus MC Cancer Institute
- Enrollment
- 138
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with CRLM treated with curative intent
- •Age \= 18 years
- •ECOG performance status \= 2 (Appendix A)
- •Histologically confirmed and previously resected primary colorectal carcinoma
- •Disease\-free at three to six months after CRLM treatment (assessed by medical imaging)
Exclusion Criteria
- •Metastatic extrahepatic disease (EHD) precluding curative treatment of CRLM
- •Patients with confirmed hereditary CRC
- •Patients enrolled in other studies that require strict adherence to any specific follow\-up practice with regular imaging – yearly or more frequent – of the abdomen and/or thorax
- •Patients with comorbidity that requires imaging of the abdomen and/or thorax every year or more frequent
- •Inability to complete the questionnaires due to illiteracy and/or insufficient proficiency of the Dutch language
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Follow-up after surgery for colorectal liver metastasis: the prospective multicentre FUTURE-mets studyNL-OMON52640Erasmus MC, Universitair Medisch Centrum Rotterdam138
Recruiting
Not Applicable
Follow-up after surgery for colorectal cancer: the FUTURE-primary implementation studyNL-OMON27170Dr. D.J. Grünhagen, Erasmus MC Cancer Institute200
Recruiting
Not Applicable
Follow-up after surgery for colorectal cancer: the prospective, multicentre FUTURE-primary implementation study.colon cancerColorectal cancer10017990NL-OMON52113Erasmus MC, Universitair Medisch Centrum Rotterdam200
Completed
Not Applicable
Surgery for colorectal liver metastases in the setting of extrahepatic disease in the era of multidisciplinary approachesExtrahepatic disease from colorectal cancerJPRN-UMIN000029660Cancer Institute Hospital of the Japanese Foundation for Cancer Research581
Completed
Phase 2
on-resectable colorectal liver metastases treated with cetuximab induction toward liver R0 resection trialJPRN-UMIN000007923Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo50